|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Catalyst Biosciences
| | | Phone: | (650) 871-0761 | Fax: | (650) 871-2475 | Year Established: | 2003 | Ticker: | CBIO | Exchange: | NASDAQ | Main Contact: | Jeffrey Landau, B.S., M.B.A., VP, Business Development | | Other Contacts: | Nassim Usman, Ph.D., President & CEO Howard Levy, M.B.B.Ch., Ph.D., M.M.M., CMO Fletcher Payne, CFO Andrew Hetherington, M.B.A., VP, Manufacturing Operations Grant Blouse, Ph.D., VP, Translational Research
| | Company Description | Catalyst is a clinical-stage biopharmaceutical company focused on creating and developing novel medicines to address serious medical conditions. To date, Catalyst has focused its product development efforts in the fields of hemostasis, including the treatment of hemophilia and surgical bleeding, and inflammation, including prevention of delayed graft function in renal transplants and the treatment of dry age-related macular degeneration, a condition that can cause visual impairment or blindness. Catalyst’s most advanced program is an improved next-generation coagulation Factor VIIa variant, CB 813d, which has successfully completed a Phase 1 clinical trial in severe hemophilia A and B patients. In addition to Catalyst’s lead Factor VIIa program, Catalyst has two other next-generation coagulation factors, a Factor IX variant, CB 2679d/ISU 304, that is in advanced preclinical development, and a Factor Xa variant, that is in the advanced lead stage of development. | |
|
|
|
|
|